灵康药业：关于控股股东部分股份办理质押的公告

Core Viewpoint - Lingkang Pharmaceutical announced that its controlling shareholder, Lingkang Holding Group Co., Ltd., has pledged 54 million shares, representing 15.90% of its holdings and 7.49% of the company's total share capital, for its own production and operation purposes [1] Summary by Categories - Share Pledge Details - The number of shares pledged is 54 million [1] - This represents 15.90% of the controlling shareholder's total holdings [1] - The pledged shares account for 7.49% of the company's total share capital [1] - Purpose of Pledge - The purpose of the share pledge is for the controlling shareholder's own production and operation [1]